about
Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.Prevention of portal hypertension: from variceal development to clinical decompensationReversibility and heritability of liver fibrosis: Implications for research and therapyMetabolic and cardiovascular complications in the liver transplant recipientStaging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individualsLyn kinase enhanced hepatic fibrosis by modulating the activation of hepatic stellate cells.Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repressionTargeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.Use of transient elastography in patients with HIV-HCV coinfection: A systematic review and meta-analysisAfter proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?Current strategies for quantitating fibrosis in liver biopsyMalnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score.Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.Treatment for hepatocellular carcinoma in elderly patients: a literature reviewAlcoholism and liver disease in Mexico: genetic and environmental factors.Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.A New Oleanolic Acid Derivative against CCl₄-Induced Hepatic Fibrosis in Rats.Management of varices in patients with cirrhosis.Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma.Shear wave elastography for liver stiffness measurement in clinical sonographic examinations: evaluation of intraobserver reproducibility, technical failure, and unreliable stiffness measurements.Future treatments of cirrhosis.Recent advances in cirrhotic cardiomyopathy.Non-invasive assessment of liver fibrosis and prognosis.Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.Probiotics for people with hepatic encephalopathy.Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity.A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.Biomarkers of bacterial translocation in advanced chronic liver disease: the key to individualizing prognosis.Association between dental infections and the clinical course of chronic liver disease.Carvedilol: the β-blocker of choice for portal hypertension?Elastography methods for the non-invasive assessment of portal hypertension.Statins in cirrhosis-Ready for prime time.Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites.Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
P2860
Q26780258-F16E3818-BC56-422D-8D91-C3ECA374C718Q26865665-1F08B917-093C-4CB4-A02A-69F8BB1774E3Q27026622-F6189A68-9C08-4A44-B677-C0A5FDDDC264Q28082243-4DDA54F9-BA1C-4DD7-9403-32488B3ED19EQ30457472-6218C87C-BDE5-4550-8646-03439410B122Q33850253-960FD3DD-AA08-474D-A45B-35BB8F0742A2Q33887116-0CEC3275-3524-45AB-9C24-DA97C822059CQ34473076-8BDD8173-6812-4B0B-8D4A-0D8D97244ED4Q34861969-5FD72222-F350-4E65-8A21-905FD770D2C7Q35948551-3DFCA2A0-8E57-4FE1-8C4B-FEAA7C42DBA9Q36246310-3B829999-780E-49B0-9A31-20AA79FA596FQ36816352-35683480-8A73-407A-B09F-3C29F9A8012FQ36893099-CAB4A495-5E6A-49C8-8EAE-1FE15FCAD0E2Q37023975-D1DDB4FD-A222-4030-8D4F-103C31CF3ADFQ37249500-08E01D05-580F-4F56-9E53-DEDBD7205C92Q37358627-F3C694E2-BFFB-424A-B37B-37CECDAFCD75Q37511482-171C67B9-CAE2-4978-9873-B15E24A53272Q37681886-4649A045-E7D5-4DF2-AF67-B1C388090C41Q37706081-B704B462-AA9A-4701-9024-FBA08A2C9DFAQ37729132-52AEE5DA-7AFD-4CCA-B909-F73845DD3158Q38094881-702C9EE1-0652-4F66-B198-B2481B149572Q38118780-18DD79F6-E6A2-4659-B522-AE3D1347A0E9Q38190931-479F1DAD-BD28-4648-B44F-8C9496532741Q38218607-E993143E-B3EC-421D-BC68-FBFCCCA02C74Q38268965-7417940A-5316-49FD-8643-8E2F5666920CQ38588078-3C135710-A597-42E9-BEC7-A251F49D4681Q38664525-4235558F-5514-4880-9A96-EF903F1122C5Q38858262-9F56F5D5-ABE6-4E88-9AA6-621BA1ADD571Q38946102-162C5E47-DF26-4E60-9B31-B9472AB9C82DQ38950703-515C1C18-8656-4CF5-AAE4-0C15FEAC752EQ40375007-DE3E5EE0-C33A-43F1-9DEE-5D111BA2C1C3Q40706124-9D0C3321-E985-48FD-8726-388C5881708AQ41519742-47488E3B-B785-47C0-85FD-CB957AC6B1DDQ41902298-75461681-0A1B-4989-987C-F93249FFC898Q44069232-C7F1D14B-5D6B-45DA-90CD-FC7FBC7AB878Q46186827-5875D549-25A2-43B6-AE28-0DDFC461FC2EQ47707779-D39CEAE6-8283-4452-9E3D-4A4A0B48F4F2Q48097930-897792A4-E719-4906-8446-A1308970B50DQ48122792-D7D5CFD1-691B-4350-A8AD-63C4774E0EACQ48140668-15925BF9-102A-41BB-B295-36898259AFEB
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
New therapeutic paradigm for patients with cirrhosis.
@en
type
label
New therapeutic paradigm for patients with cirrhosis.
@en
prefLabel
New therapeutic paradigm for patients with cirrhosis.
@en
P2860
P356
P1433
P1476
New therapeutic paradigm for patients with cirrhosis.
@en
P2093
Jaime Bosch
P2860
P304
P356
10.1002/HEP.25915
P407
P577
2012-11-01T00:00:00Z